Information  X 
Enter a valid email address

Synairgen PLC Ord 1P (SNG)

Date Time Source Announcement
23 Jun 2022 4:40 pm
RNS
Second Price Monitoring Extn
  4:35 pm
RNS
Price Monitoring Extension
15 Jun 2022 2:30 pm
RNS
Holding(s) in Company
09 Jun 2022 3:00 pm
RNS
Exercise of Options and Total Voting Rights
06 Jun 2022 4:25 pm
RNS
Posting of Annual Report & Notice of AGM
25 May 2022 7:00 am
RNS
Full Year Results
18 May 2022 4:36 pm
RNS
Price Monitoring Extension
16 May 2022 7:00 am
RNS
Synairgen presents at ATS 2022
25 Apr 2022 7:00 am
RNS
Presentation at ECCMID
19 Apr 2022 4:40 pm
RNS
Second Price Monitoring Extn
  4:35 pm
RNS
Price Monitoring Extension
06 Apr 2022 2:10 pm
RNS
Holding(s) in Company
05 Apr 2022 7:00 am
RNS
Synairgen to present at ATS 2022
17 Mar 2022 7:25 am
RNS
Synairgen Provides Update on ACTIV-2 Trial
14 Mar 2022 4:41 pm
RNS
Second Price Monitoring Extn
  4:36 pm
RNS
Price Monitoring Extension
11 Mar 2022 4:40 pm
RNS
Second Price Monitoring Extn
  4:35 pm
RNS
Price Monitoring Extension
08 Mar 2022 4:35 pm
RNS
Holding(s) in Company
  3:52 pm
RNS
Holding(s) in Company
04 Mar 2022 1:36 pm
RNS
Holding(s) in Company
03 Mar 2022 7:00 am
RNS
Update on SNG001
24 Feb 2022 11:30 am
RNS
Holding(s) in Company
23 Feb 2022 11:25 am
RNS
Holding(s) in Company
21 Feb 2022 7:00 am
RNS
Topline results from Phase 3 SPRINTER trial
04 Feb 2022 4:54 pm
RNS
Holding(s) in Company
28 Jan 2022 7:00 am
RNS
Director/PDMR Shareholding
19 Jan 2022 2:05 pm
RNS
Holding(s) in Company
12 Jan 2022 11:53 am
RNS
Holding(s) in Company
07 Jan 2022 5:25 pm
RNS
Holding(s) in Company
06 Jan 2022 12:00 pm
RNS
Synairgen announces partnership with Ashfield
23 Dec 2021 4:15 pm
RNS
Holding(s) in Company
  2:19 pm
RNS
Holding(s) in Company
21 Dec 2021 5:05 pm
RNS
Holding(s) in Company
08 Dec 2021 7:00 am
RNS
Data Presented at ESWI Influenza Conference
06 Dec 2021 5:30 pm
RNS
Holding(s) in Company
  7:00 am
RNS
Synairgen Presents SNG001 Data at ESWI
19 Nov 2021 2:26 pm
RNS
Holding(s) in Company
11 Nov 2021 7:00 am
RNS
Synairgen completes Phase III recruitment
08 Nov 2021 12:58 pm
RNS
Holding(s) in Company
26 Oct 2021 3:13 pm
RNS
Holding(s) in Company
21 Oct 2021 5:39 pm
RNS
Holdings in Company
  7:00 am
RNS
Grant of Options
20 Oct 2021 7:00 am
RNS
SNG001 progresses to Phase 3 of ACTIV-2 trial
13 Oct 2021 7:00 am
RNS
Synairgen appoints Gareth Walters, Ph.D. as CRO
05 Oct 2021 11:25 am
RNS
Holding(s) in Company
30 Sep 2021 7:02 am
RNS
Non-Executive Director Appointment
  7:02 am
GNW
Non-Executive Director Appointment
  7:01 am
GNW
Interim results for the six months ended 30 June 2021
  7:00 am
RNS
Interim results
21 Sep 2021 7:00 am
RNS
Synairgen Notice of Interim Results
10 Sep 2021 11:30 am
RNS
Holding(s) in Company
12 Aug 2021 4:12 pm
RNS
Exercise of Options and Total Voting Rights
06 Aug 2021 12:21 pm
RNS
Holding(s) in Company
29 Jun 2021 4:28 pm
RNS
Holding(s) in Company
18 Jun 2021 10:29 am
RNS
Result of AGM
07 Jun 2021 7:00 am
RNS
Grant of Options
25 May 2021 4:28 pm
RNS
Notice of AGM
24 May 2021 7:00 am
RNS
Results of in vitro studies
  7:00 am
GNW
Synairgen announces results of in vitro studies showing antiviral activity of interferon beta against key SARS-CoV-2 variants

a d v e r t i s e m e n t